Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,398.00
Bid: 12,100.00
Ask: 12,600.00
Change: 0.00 (0.00%)
Spread: 500.00 (4.132%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: Lloyds declines as state investment vehicle lowers stake, miners lower

Mon, 01st Jun 2015 13:49

UK shares were trading lower on Monday afternoon, ahead of a raft of US economic data, as weakness in mining, oil and insurance stocks outweighed gains made in the real estate, travel and electronics sectors.As of 15:30 BST, the FTSE 100 was trading 0.23% lower at 6,988.Lloyds registered losses as UK Financial Investments, the state investment vehicle, lowered its stake to 18.99% from the 19.93% it held on 12 May. The move follows continued market speculation surrounding the timing public share-selling, with the aim of returning the lender wholly to private ownership, possibly as early as September.Morrison dipped ahead of this week's annual meeting, as investors are expected to object to former chief executive Dalton Phillips's substantial payoff. The company is also at risk of being removed from the FTSE 100 altogether, to be replaced by satellite communications group Inmarsat.Prudential was also weaker as it appointed Barry Stowe as chairman and chief executive of its North American business.Miners Fresnillo, Anglo American and Glencore were in the red following weak manufacturing data from China, the world's biggest metals consumer. Oil giants Weir Group and Shell also declined, as oil prices retreated from last week's highs.Shell was also hit with allegations that it tried to use its connections with the Science Museum to influence the presentation of its Climate Change programme. A leaked internal email expressed concerns that a particular part of the project sponsored by the company "creates an opportunity for NGOs [non-governmental organisations] to talk about some of the issues that concern them around Shell's operations".Astrazeneca was boosted by positive takeaways from the annual meeting of the American Society of Clinical Oncology, during which the company presented preliminary data for one of its lung cancer drugs.WPP was trading higher, despite reports that it could face opposition from shareholders at its annual meeting on 9 June over chief executive Martin Sorrell's £43m pay award for 2014. Glass Lewis and Institutional Shareholder Services (ISS), which advise investors that own about a quarter of the equities on the UK stock market, have both raised concerns about the 40% increase, according to The Financial Times.RisersAshtead Group (AHT) 1,155.00p +3.12%Dixons Carphone (DC.) 485.40p +2.10%International Consolidated Airlines Group SA (CDI) (IAG) 564.00p +1.81%British Land Company (BLND) 877.00p +1.74%St James's Place (STJ) 926.00p +1.59%Intertek Group (ITRK) 2,540.00p +1.56%InterContinental Hotels Group (IHG) 2,781.00p +1.46%Land Securities Group (LAND) 1,332.00p +1.45%Lloyds Banking Group (LLOY) 88.95p +1.34%Taylor Wimpey (TW.) 185.80p +1.25%FallersWeir Group (WEIR) 1,978.00p -2.27%Standard Chartered (STAN) 1,033.00p -1.24%Glencore (GLEN) 284.65p -1.15%Royal Dutch Shell 'B' (RDSB) 1,956.00p -0.89%Anglo American (AAL) 1,017.00p -0.88%Imperial Tobacco Group (IMT) 3,341.00p -0.86%Kingfisher (KGF) 366.90p -0.84%Barclays (BARC) 268.10p -0.70%Aggreko (AGK) 1,597.00p -0.68%Mondi (MNDI) 1,466.00p -0.68%
More News
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.